Aslan aims to boost clinical capabilities with new facility
TAIPEI, Taiwan – With Singapore-headquartered Aslan Pharmaceuticals Pte. Ltd. last week announcing that it had opened a new office here, the company has moved that much closer toward its goal of taking advantage of clinical trial infrastructure in Asia to develop novel medicines for global markets.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST